Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection
Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. al...
Gespeichert in:
Veröffentlicht in: | Journal of investigative dermatology 2005-07, Vol.125 (1), p.108-115 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 115 |
---|---|
container_issue | 1 |
container_start_page | 108 |
container_title | Journal of investigative dermatology |
container_volume | 125 |
creator | López-García, Belén Lee, Phillip H.A. Yamasaki, Kenshi Gallo, Richard L. |
description | Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. albicans, but this fungicidal activity was dependent on culture conditions. Evaluation of the fungal membrane by fluorescent dye penetration after incubation with cathelicidins correlated membrane permeabilization and inhibition of fungal growth. Anti-fungal assays carried out in an ionic environment that mimicked human sweat and with the processed forms of cathelicidin such as are present in sweat found that the cleavage of LL-37 to forms such as RK-31 conferred additional activity against C. albicans. C. albicans also induced an increase in the expression of cathelicidin in mouse skin, but this induction did not confer systemic or subcutaneous resistance as mCRAMP-deficient mice were not more susceptible to C. albicans in blood-killing assays or in an intradermal infection model. Therefore, cathelicidins appear active against C. albicans, but may be most effective as a superficial barrier to infection. |
doi_str_mv | 10.1111/j.0022-202X.2005.23713.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67981337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022202X15323514</els_id><sourcerecordid>1044440291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-a19aa3de6a354f0684a1d882d738fe039e0e3c6924ffdb2785bf931b6a5b0cc33</originalsourceid><addsrcrecordid>eNqFkV1LHDEYhUNp0a31L5TgRe9mzMd8ZC63i9sKgqVV6F3IJG8062xikxnRf9-Muyh4Y25CwnPOy3sOQpiSkuZzuikJYaxghP0tGSF1yXhLefn4AS1ozXhB26r9iBYv0CH6nNKGENpUtThAh7TuBOOULJBa-tEV68nfqAEv9ege3PiEg8UrNd7C4LQzziesvMH57SL-FUbIkkz_DgNg5zPpjTMKq6F3WmX4z13-PfcWsl3wX9Anq4YEx_v7CF2vz65WP4uLyx_nq-VFoStBxkLRTiluoFG8rixpRKWoEYKZlgsLhHdAgOumY5W1pmetqHvbcdo3qu6J1pwfoW873_sY_k2QRrl1ScMwKA9hSrJpO0E5b98FaeaqmooMnrwBN2GKPi8hGSU58Y7PY8UO0jGkFMHK--i2Kj5JSuRcltzIuQc59yDnsuRzWfIxS7_u_ad-C-ZVuG8nA993AOTcHhxEmbQDr8G4mMOVJrj3p_wHVqeldA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>210371933</pqid></control><display><type>article</type><title>Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><source>ProQuest Central</source><creator>López-García, Belén ; Lee, Phillip H.A. ; Yamasaki, Kenshi ; Gallo, Richard L.</creator><creatorcontrib>López-García, Belén ; Lee, Phillip H.A. ; Yamasaki, Kenshi ; Gallo, Richard L.</creatorcontrib><description>Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. albicans, but this fungicidal activity was dependent on culture conditions. Evaluation of the fungal membrane by fluorescent dye penetration after incubation with cathelicidins correlated membrane permeabilization and inhibition of fungal growth. Anti-fungal assays carried out in an ionic environment that mimicked human sweat and with the processed forms of cathelicidin such as are present in sweat found that the cleavage of LL-37 to forms such as RK-31 conferred additional activity against C. albicans. C. albicans also induced an increase in the expression of cathelicidin in mouse skin, but this induction did not confer systemic or subcutaneous resistance as mCRAMP-deficient mice were not more susceptible to C. albicans in blood-killing assays or in an intradermal infection model. Therefore, cathelicidins appear active against C. albicans, but may be most effective as a superficial barrier to infection.</description><identifier>ISSN: 0022-202X</identifier><identifier>EISSN: 1523-1747</identifier><identifier>DOI: 10.1111/j.0022-202X.2005.23713.x</identifier><identifier>PMID: 15982310</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; anti-microbial peptides ; Antifungal Agents - pharmacology ; Antimicrobial Cationic Peptides - metabolism ; Candida albicans ; Candida albicans - drug effects ; Candidiasis, Cutaneous - physiopathology ; defensins ; Humans ; In Vitro Techniques ; infection ; innate immunity ; LL-37 ; mCRAMP ; Mice ; sweat</subject><ispartof>Journal of investigative dermatology, 2005-07, Vol.125 (1), p.108-115</ispartof><rights>2005 The Society for Investigative Dermatology, Inc</rights><rights>Copyright Nature Publishing Group Jul 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-a19aa3de6a354f0684a1d882d738fe039e0e3c6924ffdb2785bf931b6a5b0cc33</citedby><cites>FETCH-LOGICAL-c480t-a19aa3de6a354f0684a1d882d738fe039e0e3c6924ffdb2785bf931b6a5b0cc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/210371933?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15982310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>López-García, Belén</creatorcontrib><creatorcontrib>Lee, Phillip H.A.</creatorcontrib><creatorcontrib>Yamasaki, Kenshi</creatorcontrib><creatorcontrib>Gallo, Richard L.</creatorcontrib><title>Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection</title><title>Journal of investigative dermatology</title><addtitle>J Invest Dermatol</addtitle><description>Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. albicans, but this fungicidal activity was dependent on culture conditions. Evaluation of the fungal membrane by fluorescent dye penetration after incubation with cathelicidins correlated membrane permeabilization and inhibition of fungal growth. Anti-fungal assays carried out in an ionic environment that mimicked human sweat and with the processed forms of cathelicidin such as are present in sweat found that the cleavage of LL-37 to forms such as RK-31 conferred additional activity against C. albicans. C. albicans also induced an increase in the expression of cathelicidin in mouse skin, but this induction did not confer systemic or subcutaneous resistance as mCRAMP-deficient mice were not more susceptible to C. albicans in blood-killing assays or in an intradermal infection model. Therefore, cathelicidins appear active against C. albicans, but may be most effective as a superficial barrier to infection.</description><subject>Animals</subject><subject>anti-microbial peptides</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antimicrobial Cationic Peptides - metabolism</subject><subject>Candida albicans</subject><subject>Candida albicans - drug effects</subject><subject>Candidiasis, Cutaneous - physiopathology</subject><subject>defensins</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>infection</subject><subject>innate immunity</subject><subject>LL-37</subject><subject>mCRAMP</subject><subject>Mice</subject><subject>sweat</subject><issn>0022-202X</issn><issn>1523-1747</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkV1LHDEYhUNp0a31L5TgRe9mzMd8ZC63i9sKgqVV6F3IJG8062xikxnRf9-Muyh4Y25CwnPOy3sOQpiSkuZzuikJYaxghP0tGSF1yXhLefn4AS1ozXhB26r9iBYv0CH6nNKGENpUtThAh7TuBOOULJBa-tEV68nfqAEv9ege3PiEg8UrNd7C4LQzziesvMH57SL-FUbIkkz_DgNg5zPpjTMKq6F3WmX4z13-PfcWsl3wX9Anq4YEx_v7CF2vz65WP4uLyx_nq-VFoStBxkLRTiluoFG8rixpRKWoEYKZlgsLhHdAgOumY5W1pmetqHvbcdo3qu6J1pwfoW873_sY_k2QRrl1ScMwKA9hSrJpO0E5b98FaeaqmooMnrwBN2GKPi8hGSU58Y7PY8UO0jGkFMHK--i2Kj5JSuRcltzIuQc59yDnsuRzWfIxS7_u_ad-C-ZVuG8nA993AOTcHhxEmbQDr8G4mMOVJrj3p_wHVqeldA</recordid><startdate>20050701</startdate><enddate>20050701</enddate><creator>López-García, Belén</creator><creator>Lee, Phillip H.A.</creator><creator>Yamasaki, Kenshi</creator><creator>Gallo, Richard L.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7QL</scope><scope>7U9</scope><scope>C1K</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20050701</creationdate><title>Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection</title><author>López-García, Belén ; Lee, Phillip H.A. ; Yamasaki, Kenshi ; Gallo, Richard L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-a19aa3de6a354f0684a1d882d738fe039e0e3c6924ffdb2785bf931b6a5b0cc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>anti-microbial peptides</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antimicrobial Cationic Peptides - metabolism</topic><topic>Candida albicans</topic><topic>Candida albicans - drug effects</topic><topic>Candidiasis, Cutaneous - physiopathology</topic><topic>defensins</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>infection</topic><topic>innate immunity</topic><topic>LL-37</topic><topic>mCRAMP</topic><topic>Mice</topic><topic>sweat</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>López-García, Belén</creatorcontrib><creatorcontrib>Lee, Phillip H.A.</creatorcontrib><creatorcontrib>Yamasaki, Kenshi</creatorcontrib><creatorcontrib>Gallo, Richard L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of investigative dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>López-García, Belén</au><au>Lee, Phillip H.A.</au><au>Yamasaki, Kenshi</au><au>Gallo, Richard L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection</atitle><jtitle>Journal of investigative dermatology</jtitle><addtitle>J Invest Dermatol</addtitle><date>2005-07-01</date><risdate>2005</risdate><volume>125</volume><issue>1</issue><spage>108</spage><epage>115</epage><pages>108-115</pages><issn>0022-202X</issn><eissn>1523-1747</eissn><abstract>Cathelicidins have broad anti-microbial capacity and are important for host defense against skin infections by some bacterial and viral pathogens. This study investigated the activity of cathelicidins against Candida albicans. The human cathelicidin LL-37, and mouse cathelicidin mCRAMP, killed C. albicans, but this fungicidal activity was dependent on culture conditions. Evaluation of the fungal membrane by fluorescent dye penetration after incubation with cathelicidins correlated membrane permeabilization and inhibition of fungal growth. Anti-fungal assays carried out in an ionic environment that mimicked human sweat and with the processed forms of cathelicidin such as are present in sweat found that the cleavage of LL-37 to forms such as RK-31 conferred additional activity against C. albicans. C. albicans also induced an increase in the expression of cathelicidin in mouse skin, but this induction did not confer systemic or subcutaneous resistance as mCRAMP-deficient mice were not more susceptible to C. albicans in blood-killing assays or in an intradermal infection model. Therefore, cathelicidins appear active against C. albicans, but may be most effective as a superficial barrier to infection.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15982310</pmid><doi>10.1111/j.0022-202X.2005.23713.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-202X |
ispartof | Journal of investigative dermatology, 2005-07, Vol.125 (1), p.108-115 |
issn | 0022-202X 1523-1747 |
language | eng |
recordid | cdi_proquest_miscellaneous_67981337 |
source | MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library; ProQuest Central |
subjects | Animals anti-microbial peptides Antifungal Agents - pharmacology Antimicrobial Cationic Peptides - metabolism Candida albicans Candida albicans - drug effects Candidiasis, Cutaneous - physiopathology defensins Humans In Vitro Techniques infection innate immunity LL-37 mCRAMP Mice sweat |
title | Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A16%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-Fungal%20Activity%20of%20Cathelicidins%20and%20their%20Potential%20Role%20in%20Candida%20albicans%20Skin%20Infection&rft.jtitle=Journal%20of%20investigative%20dermatology&rft.au=L%C3%B3pez-Garc%C3%ADa,%20Bel%C3%A9n&rft.date=2005-07-01&rft.volume=125&rft.issue=1&rft.spage=108&rft.epage=115&rft.pages=108-115&rft.issn=0022-202X&rft.eissn=1523-1747&rft_id=info:doi/10.1111/j.0022-202X.2005.23713.x&rft_dat=%3Cproquest_cross%3E1044440291%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=210371933&rft_id=info:pmid/15982310&rft_els_id=S0022202X15323514&rfr_iscdi=true |